| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-10 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |